Potential Predictors for Serofast State After Treatment Among HIV-Negative Persons with Syphilis in China: A Systematic Review and Meta-Analysis

Overview

Journal Iran J Public Health

Date 2015 Apr 24

PMID 25905049

Citations 10

Authors

Jiabi Qin

Tubao Yang

Hua Wang

Tiejian Feng

Xiaoying Liu

Affiliations

Soon will be listed here.

Abstract

Background: Several studies have been conducted in China in order to investigate the potential predictors of serofast state after treatment among syphilitic patients. However, there is a remarkable diversity among the results. This meta-analysis was conducted to assess potential predictors of serofast among syphilitic patients in China.

Methods: International and national electronic databases were searched up to September 2013. Reference lists of retrieved articles were also reviewed. Cohort or case-control studies addressing risk factors of serofast among syphilitic patients were included in this study.

Results: We assessed 27 separate studies involving overall 6682 HIV-negative participants with syphilis of which 1962 remained in the serofast state. The serofast was positively associated with older age(P trend=0.001), female(summary risk ratio[sRR]=1.50, 95%CI:1.34-;1.68), latent syphilis(sRRlatent vs primary=3.17, 95%CI: 2.66-;3.77; sRRlatent vs secondary=2.00, 95%CI: 1.48-;2.69) as well as non-penicillin treatment(sRR =2.99, 95%CI:2.45-;3.67), but negatively associated with higher baseline titers(sRR>1:32 vs ≤1:32=0.63, 95%CI: 0.54-;0.75). Compared with healthy group and serological cure group, respectively, the levels of CD4 (+), IL-2, and IL-6 among serofast patients were decreased (standardized mean difference[SMD]<0, P<0.05), but the levels of CD8(+) and IL-10 were increased(SMD>0, P<0.05). Some studies also hinted the serofast was associated with subtypes i of treponema pallidum(TP) repeat gene (RR i vs d=4.67,95%CI: 1.31-;16.69) and TP occult infection.

Conclusion: The age, gender, stage of infection, baseline titers, treatment drug, cellular immune suppression and disorders, TP occult infection and subtypes i of TP repeat gene should be considered as important predictors of serofast. However, until now the definition and mechanism of serofast has still been not clear.

Citing Articles

Investigation of the immune escape mechanism of Treponema pallidum.

Tang Y, Zhou Y, He B, Cao T, Zhou X, Ning L Infection. 2022; 51(2):305-321.

PMID: 36260281 DOI: 10.1007/s15010-022-01939-z.

An Updated Review of Recent Advances in Neurosyphilis.

Zhou J, Zhang H, Tang K, Liu R, Li J Front Med (Lausanne). 2022; 9:800383.

PMID: 36203756 PMC: 9530046. DOI: 10.3389/fmed.2022.800383.

Changes of serofast status in HIV negative asymptomatic neurosyphilis patients after treatment.

Liu J, Zhao T, Zhou C, Yan H, Lun W Front Med (Lausanne). 2022; 9:938016.

PMID: 35991658 PMC: 9381919. DOI: 10.3389/fmed.2022.938016.

Management of Adult Syphilis: Key Questions to Inform the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

Tuddenham S, Ghanem K Clin Infect Dis. 2022; 74(Suppl_2):S127-S133.

PMID: 35416969 PMC: 9006973. DOI: 10.1093/cid/ciac060.

Decreased blood natural killer cells in serofast patients: a systematic review and meta-analysis.

Cheng W, Lu Y, Chen R, Ren H, Hu W Cent Eur J Immunol. 2022; 46(4):509-515.

PMID: 35125951 PMC: 8808302. DOI: 10.5114/ceji.2021.111540.

References

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Tong M, Lin L, Liu G, Zhang H, Zeng Y, Zheng W . Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis. PLoS One. 2013; 8(7):e70102. PMC: 3720935. DOI: 10.1371/journal.pone.0070102. View

Chen X, Wang Q, Yin Y, Liang G, Jiang N, Yang L . Prevalence of syphilis infection in different tiers of female sex workers in China: implications for surveillance and interventions. BMC Infect Dis. 2012; 12:84. PMC: 3352076. DOI: 10.1186/1471-2334-12-84. View

Todd J, Munguti K, Grosskurth H, Mngara J, Changalucha J, Mayaud P . Risk factors for active syphilis and TPHA seroconversion in a rural African population. Sex Transm Infect. 2001; 77(1):37-45. PMC: 1758332. DOI: 10.1136/sti.77.1.37. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Dionne-Odom J, Karita E, Kilembe W, Henderson F, Vwalika B, Bayingana R . Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. Clin Infect Dis. 2013; 56(12):1829-37. PMC: 3658364. DOI: 10.1093/cid/cit146. View

Lin L, Tong M, Fu Z, Dan B, Zheng W, Zhang C . Evaluation of a colloidal gold immunochromatography assay in the detection of Treponema pallidum specific IgM antibody in syphilis serofast reaction patients: a serologic marker for the relapse and infection of syphilis. Diagn Microbiol Infect Dis. 2011; 70(1):10-6. DOI: 10.1016/j.diagmicrobio.2010.11.015. View

Newman L, Kamb M, Hawkes S, Gomez G, Say L, Seuc A . Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med. 2013; 10(2):e1001396. PMC: 3582608. DOI: 10.1371/journal.pmed.1001396. View

10.

Workowski K, Berman S . Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006; 55(RR-11):1-94. View

11.

Sena A, Wolff M, Martin D, Behets F, Van Damme K, Leone P . Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis. Clin Infect Dis. 2011; 53(11):1092-9. PMC: 3205200. DOI: 10.1093/cid/cir671. View

12.

Romanowski B, Sutherland R, Fick G, Mooney D, Love E . Serologic response to treatment of infectious syphilis. Ann Intern Med. 1991; 114(12):1005-9. DOI: 10.7326/0003-4819-114-12-1005. View

13.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

14.

Li J, Wang L, Zuo Y, Liu Y, Liu X, Lei Y . [Clinical analysis and study of immunological function in syphilis patients with seroresistance]. Zhonghua Yi Xue Za Zhi. 2009; 89(12):813-6. View

15.

Chen X, Yin Y, Wang Q, Wang B . Historical perspective of syphilis in the past 60 years in China: eliminated, forgotten, on the return. Chin Med J (Engl). 2013; 126(14):2774-9. View

16.

Leader B, Hevner K, Molini B, Barrett L, Van Voorhis W, Lukehart S . Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum. Infect Immun. 2003; 71(10):6054-7. PMC: 201100. DOI: 10.1128/IAI.71.10.6054-6057.2003. View

17.

Li J, Wang L, Zheng H . Predictors of serological cure and serofast state after treatment in HIV-negative patients with early syphilis in China. Sex Transm Infect. 2012; 89(1):69. DOI: 10.1136/sextrans-2012-050711. View

18.

Lin L, Zheng W, Tong M, Fu Z, Liu G, Fu J . Further evaluation of the characteristics of Treponema pallidum-specific IgM antibody in syphilis serofast reaction patients. Diagn Microbiol Infect Dis. 2011; 71(3):201-7. DOI: 10.1016/j.diagmicrobio.2011.07.005. View

19.

Fisman D . Syphilis resurgent in China. Lancet. 2007; 369(9556):84-5. DOI: 10.1016/S0140-6736(07)60044-0. View

20.

Wang L, Zuo Y, Liu Y, Liu X, Zheng H . [Incidence of seroresistance of syphilis and its relevant factors]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008; 30(3):338-41. View